Related Experiment Videos
Multiple sclerosis associated agent (MSAA): failure to confirm an association with multiple sclerosis
Abstract:
Recent reports indicate that a multiple sclerosis agent (MSAA) has been isolated. This agent was detected in mice by a depression in the percentage of mouse polymorphonuclear neutrophils (PMNs). We attempted to repeat these studies using coded specimens. The test, itself, was extremely variable and difficult to reproduce. In the first study, three of three multiple sclerosis (MS) patients and one of two control patients' specimens showed some PMN depression. In a repeat study of these same samples, one of three MS patients and one of two controls were associated with PMN depression. With a second set of coded specimens, one of four MS patients, one of three patients with neurologic diseases, and none of three controls showed PMN depression. We were unable to confirm the presence of MSAA and conclude that the results were random.
Insights
Researchers could not replicate findings of a multiple sclerosis agent (MSAA) that depresses polymorphonuclear neutrophils (PMNs). The assay showed high variability, suggesting previous results were likely random occurrences.
Area of Science:
- Immunology
- Neurology
- Biomedical Research
Background:
- Previous studies suggested the isolation of a multiple sclerosis agent (MSAA).
- This proposed agent was reportedly detected via depression of mouse polymorphonuclear neutrophils (PMNs).
Purpose of the Study:
- To independently verify the existence and detection method of the multiple sclerosis agent (MSAA).
- To assess the reproducibility of the PMN depression assay for MSAA detection.
Main Methods:
- Attempted to replicate previous studies using coded patient and control specimens.
- Administered a polymorphonuclear neutrophil (PMN) depression assay.
- Conducted multiple experimental runs with different sets of coded samples.
Main Results:
- The PMN depression assay demonstrated significant variability and was difficult to reproduce across multiple attempts.
- Inconsistent results were observed, with PMN depression occurring sporadically in multiple sclerosis (MS) patients, controls, and patients with other neurologic diseases.
- No consistent pattern emerged to confirm the presence of the proposed MSAA.
Conclusions:
- The study failed to confirm the existence of the multiple sclerosis agent (MSAA) as reported.
- The observed PMN depression results are attributed to random variation within the highly variable assay.
- Further investigation into the reliability of the MSAA detection assay is warranted.